f.wojcik
TL2 · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 30 January 2025 · last posted 22h
68 posts, newest first. Showing up to 150.
-
Immortal time bias in a claims-database study — one year on Replied, post #47 · Evidence › Study critique · 27 Jul 2026 · 4 likes Where the Immortal time bias reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Journal club: LEADER as the historical anchor Replied, post #110 · Evidence › Journal club · 26 Jul 2026 · 5 likes Adding what did not work for me on LEADER, since the failures never get written up and they are half the useful information.
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #27 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Documenting a supplier's response to a discrepancy Replied, post #46 · Sourcing › Vendor reports · 23 Jul 2026 · 3 likes Coming back to post #44, because the follow-up matters more than the original answer. Reports of ordinary results are more valuable than reports of remarkable ones,…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #112 · Evidence › Journal club · 17 Jul 2026 · 11 likes SURMOUNT-OSA came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Programming during a large energy deficit Replied, post #40 · Nutrition & Training › Resistance training · 15 Jul 2026 · 0 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose. It cost nothing to check and would have cost…
-
Revisiting: The best-written scientific paper you have read Replied, post #88 · Lounge › Off topic · 13 Jul 2026 · 6 likes Having read the whole best-written scientific paper thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #10 · Evidence › Study critique · 7 Jul 2026 · 2 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Since Selection keeps coming up, it should probably be a maintained page rather than…
-
What I would want from a home test that does not exist yet Replied, post #30 · Analytics › Home & field testing · 7 Jul 2026 · 3 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. A home refractometer is not measuring what people hope it is measuring in these…
-
Tracking intake honestly when appetite is absent Replied, post #88 · Nutrition & Training › Protein & intake · 7 Jul 2026 · 9 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #72 · Evidence › Journal club · 1 Jul 2026 · 32 likes I read post #68 twice before replying, because I had assumed the opposite. Reading order that works for these sessions: registry entry, methods, baseline table, primary…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #42 · Access › International · 28 Jun 2026 · 0 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. Small point, but it is the one that…
-
Follow-up: UK access routes, dated and sourced Replied, post #7 · Regional › UK & Ireland · 26 Jun 2026 · 4 likes Members outside these two jurisdictions reading this thread should note that none of it transfers, including the parts that sound general.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #94 · Practice › Reconstitution · 22 Jun 2026 · 3 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Micronutrient adequacy at low total intake Started this topic · Nutrition & Training › Protein & intake · 4 Jun 2026 · 8 likes Micronutrient adequacy at low total intake — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #4 · Analytics › HPLC & UHPLC · 3 Jun 2026 · 20 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Nobody has said the unglamorous part of Carryover yet, so: most of the…
-
Coming back to: A structured critique template this community uses Replied, post #22 · Evidence › Study critique · 30 May 2026 · 0 likes Post #20 put the caveat in the right place and I want to underline it. Blinding, duration and comparator choice trade against each other. Improving one usually costs…
-
How much fluid is actually needed, and how you would know Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 27 May 2026 · 0 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #9 · marked as the solution · Compounds › Oral incretins · 20 May 2026 · 12 likes Everything in post #5 holds. The case it does not cover is the one I have. The absorption enhancer in the licensed oral product works by transiently raising local…
-
Revisiting: What pooling buys you and what it destroys Replied, post #27 · Evidence › Meta-analyses · 19 May 2026 · 19 likes Adding the measurement that post #24 says would settle it. One caution on pooling buys: everything above assumes the underlying documentation is what it claims to be.…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #4 · Clinical › Bloodwork · 16 May 2026 · 2 likes I had written a reply contradicting post #2 and deleted it. Here is what survived. TSH and free hormones: TSH is a reasonable screening test but does not tell you about…
-
Reused chromatograms across lots: how to spot it Replied, post #39 · Analytics › COA interpretation · 6 May 2026 · 9 likes I think the reused chromatograms across lots question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
An 18-month record including the parts that went badly Replied, post #9 · Outcomes › Progress reports · 4 May 2026 · 28 likes Answering the question post #7 raises rather than the one it answers. A single scale used throughout beats a more accurate scale introduced halfway through. Consistency…
-
Spreadsheets: an appreciation — what changed since Replied, post #31 · Lounge › Off topic · 30 Apr 2026 · 22 likes Two claims get bundled together under Spreadsheets and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #5 · Clinical › Comorbidities · 19 Apr 2026 · 2 likes Registry and observational data covering excluded populations is accumulating and is weaker evidence than a trial and better than nothing. I would put the burden of…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #47 · Data & Tools › Calculators · 7 Apr 2026 · 1 like A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
-
Follow-up: Search filters: what is missing Replied, post #64 · Meta › Site feedback · 29 Mar 2026 · 1 like On post #62 — agreed on the reasoning, with one qualification. Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility.…
-
Reading U-100 graduations, with a conversion table Replied, post #18 · Devices › Syringes & needles · 26 Mar 2026 · 1 like For anyone finding this later: the short answer on reading U-100 graduations is that it depends on one thing, and the rest of the thread is people identifying which…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #30 · Analytics › Mass spectrometry · 25 Mar 2026 · 5 likes I read post #26 twice before replying, because I had assumed the opposite. A definition problem is doing most of the work in this Charge states discussion. Once the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #54 · Practice › Dosing & titration · 6 Feb 2026 · 3 likes Coming back to post #50, because the follow-up matters more than the original answer. Concentration and dose get conflated constantly in this subcategory. Changing how…
-
Trifluoroacetate content and its consequences Replied, post #35 · Analytics › Impurities & related substances · 28 Jan 2026 · 16 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #129 · Compounds › Oral incretins · 5 Jan 2026 · 24 likes Seconded. It reads as careful rather than confident, which is the right register.
-
When to stop reading forums, including this one Replied, post #63 · Wellbeing › Mental health · 17 Dec 2025 · 26 likes Worth separating two things that post #62 runs together. Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #78 · Compounds › Oral incretins · 6 Dec 2025 · 0 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #70 · Compounds › Oral incretins · 6 Dec 2025 · 1 like The arithmetic in post #68 is right; the assumption feeding it is the part to check. Timing consistency matters more for oral dosing than for weekly injection, because…
-
Substitution between formats during a shortage Replied, post #109 · Access › Shortages · 5 Dec 2025 · 7 likes Post #107 describes the usual case. This is about the unusual one. Supply interruptions: official shortage notices are published by regulatory agencies. That is the…
-
The headache that turns out to be dehydration Replied, post #65 · Nutrition & Training › Hydration & electrolytes · 21 Nov 2025 · 9 likes On headache the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Substitution between formats during a shortage Replied, post #83 · Access › Shortages · 27 Oct 2025 · 0 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. Same conclusion as the reply…
-
Sleep tracking data and its considerable limitations Replied, post #94 · Wellbeing › Sleep · 26 Oct 2025 · 1 like Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise and the trend is more usable than the nightly numbers.
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #9 · Practice › Side effects · 23 Oct 2025 · 22 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #102 · Practice › Storage & stability · 19 Oct 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Reconciling a supplier certificate with an independent result Replied, post #3 · Sourcing › Vendor reports · 9 Oct 2025 · 11 likes The opening post describes the usual case. This is about the unusual one. Include the sample handling: how it was stored, how it travelled to the laboratory, how long…
-
Specification in the result column: why that is a meaningful error Replied, post #50 · Analytics › COA interpretation · 27 Sep 2025 · 15 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #55 · Practice › Storage & stability · 18 Sep 2025 · 3 likes This follows post #52 rather than contradicting it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #119 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes The reason Aggregated purity results across four is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #57 · Compounds › Secretagogues & GH axis · 12 Aug 2025 · 1 like The arithmetic in post #56 is right; the assumption feeding it is the part to check. Evidence quality in the secretagogue literature is honestly weaker than in the…
-
Are there stupid questions here? A staff answer, at length Replied, post #49 · Start Here › Welcome · 7 Aug 2025 · 24 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
A ten-fold dose error caught before injection — one year on Replied, post #72 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Immortal time bias in a claims-database study Replied, post #11 · Evidence › Study critique · 1 Aug 2025 · 27 likes Taking post #8 at face value and following it one step further. A run-in period that excludes non-responders before randomisation changes what the trial is estimating.…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #20 · Documentation › Doc review · 2 Jul 2025 · 3 likes Promotion criteria came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
[2026 update] What we do not know about retatrutide, listed explicitly Started this topic · Compounds › Retatrutide · 1 Jul 2025 · 0 likes What we do not know about retatrutide, listed explicitly — that is the question, and I have not found it answered plainly anywhere I have looked. Putting the numbers in…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #22 · Access › Insurance & coverage · 22 Jun 2025 · 4 likes Reading a denial letter is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #150 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 0 likes Published human data on cagrilintide alone is thinner than on the combination, which is the reverse of what most people assume from how it is discussed here.
-
Antibiotics and a course of something with delayed emptying Replied, post #50 · Practice › Interactions · 26 May 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Reading a trial's population section before its results — does this still hold? Replied, post #147 · Evidence › Trials · 26 May 2025 · 8 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Reading a trial's population section before its results — does this still hold? Replied, post #95 · Evidence › Trials · 12 May 2025 · 13 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #24 · Compounds › Repair & healing peptides · 26 Apr 2025 · 30 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #19 · Evidence › Preprints · 13 Apr 2025 · 1 like Thank you — that answers what I came here to find out.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #144 · Practice › Dosing & titration · 8 Jan 2025 · 16 likes Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.
-
What changed in 2026, by region Replied, post #10 · Access › International · 6 Dec 2024 · 29 likes On post #6 — agreed on the reasoning, with one qualification. A first-hand dated account for a region with thin coverage is worth more here than any summary, and the…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #14 · Analytics › Method validation · 15 Oct 2024 · 1 like System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Converting between mg/mL and units per dose, both directions Replied, post #46 · Practice › Reconstitution · 10 Oct 2024 · 0 likes On post #42 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #22 · Analytics › Impurities & related substances · 31 Aug 2024 · 7 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
-
When a red flag was a misunderstanding, and the retraction Replied, post #6 · Sourcing › Red flags · 23 Aug 2024 · 23 likes Post #3 describes the usual case. This is about the unusual one. If you are new and reading this thread for the answer to red flag: the answer is conditional, the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #90 · Evidence › Journal club · 18 Jul 2024 · 21 likes Where I part company with post #88, and it is a narrow parting. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #36 · Evidence › Journal club · 17 Jul 2024 · 21 likes Reading rather than answering, but this is the post I would point somebody at.
-
Cold packs, phase-change material, and what survives ten days Replied, post #76 · Sourcing › Logistics · 6 Jul 2024 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
Spreadsheets: an appreciation Replied, post #24 · Lounge › Off topic · 9 Jun 2024 · 0 likes The reason spreadsheets is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.